Skinbiotherapeutics (LON:SBTX) Posts Earnings Results

Skinbiotherapeutics (LON:SBTX) announced its earnings results on Tuesday. The company reported GBX (0.94) (($0.01)) EPS for the quarter, Digital Look Earnings reports.

Shares of Skinbiotherapeutics stock traded down GBX 0.50 ($0.01) during midday trading on Thursday, reaching GBX 15 ($0.20). 148,183 shares of the company’s stock traded hands, compared to its average volume of 261,826. The company has a market cap of $19.78 million and a PE ratio of -16.67. The stock has a 50 day moving average of GBX 17.50 and a 200-day moving average of GBX 18.51. Skinbiotherapeutics has a 12 month low of GBX 12 ($0.16) and a 12 month high of GBX 26 ($0.34).

About Skinbiotherapeutics

SkinBioTherapeutics plc, a life science company, engages in the research and development of lysates derived from the human microbiome on skin. It is developing pre-clinical product application, SkinBiotix, a cosmetic cream for skin health, as well as for applications in infection control and eczema. The company was formerly known as Skinbiotix Ltd.

Featured Article: How does a dividend reinvestment plan work?

Receive News & Ratings for Skinbiotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skinbiotherapeutics and related companies with's FREE daily email newsletter.